Abstract:Introduction: The endoscopic endonasal approach (EEA) is a safe and effective treatment for pituitary adenomas (PAs). Since extracapsular resection (ER) of PAs improves tumor resection and endocrine remission rates, the interface between the pseudocapsule and gland draws increasing attention. However, it is difficult to precisely dissect the tumor along the exact boundary, and complete removal of the tumor increases the risks of normal tissue damage and cerebrospinal fluid (CSF) leakage. In this study, we investigated the extracapsular resection as well as the pseudocapsule histology to evaluate the effectiveness and safety of pseudocapsule-related surgical interventions. Methods: From December 2017 to December 2019, 189 patients of PAs via EEA in our single center were analyzed retrospectively. The images, operative details, and clinical follow-up of patients were collected. Sixty-four patients underwent pseudocapsule-based ER, and 125 patients also underwent traditional intracapsular resection (IR) with or without intensive excision for FPAs. The clinical characteristics, tumor resection, endocrinological outcomes, and postoperative morbidities of the two groups were compared. Informed consent for publication of our article was obtained from each patient. Histological examination of pseudocapsule was performed using hematoxylin and eosin and reticulin staining. Results: The gross total recession was 62 (96.9%) in the ER group and 107 (85.6%) cases in the IR group, whereas the endocrine remission rate was 29/31 (93.5%) and 40/ 53 (75.5%) cases, respectively. Anterior pituitary functions were not aggravated postoperatively in any patient, but transient diabetes insipidus (DI) occurred more in the IR group (64.0%) than in ER (48.4%). Pseudocapsule specimens were obtained in 93 patients, and clusters of small cell aggregation were detected in 11 pseudocapsule specimens (11.8%) whereas other patients showed no remarkable developed pseudocapsule. Intraoperative CSF leak occurred more in the ER group (28.1%) than in the IR group (13.6%), but no difference was seen between two groups postoperatively. No case of intracranial hematoma or pituitary crisis occurred in both groups. After a mean follow-up of 22.8 months, tumor recurrence was observed in 4 (2.1%) cases. Conclusion: Pseudocapsule-based extracapsular resection of PAs via EEA is an effective and safe procedure to achieve complete resection with high and sustained endocrine remission and without deteriorating pituitary function.

Time to Revive the Value of the Pseudocapsule in Endoscopic Endonasal Transsphenoidal Surgery for Growth Hormone Adenomas.

Extra-pseudocapsule Dissection Technique in Endoscopic Endonasal Transsphenoidal Surgery for Pituitary Adenomas

Endoscopic Transnasal Transsphenoidal Approach for the Treatment of Growth Hormone-Producing Pituitary Adenomas

Transsphenoidal pseudocapsule-based extracapsular resection for pituitary adenomas

Endonasal Endoscopic Surgery for Macroadenomas: New Understanding of Pseudocapsules

Pseudocapsule-Based Resection for Pituitary Adenomas <i>via</i> the Endoscopic Endonasal Approach

Comparative Effectiveness of Endoscopic Versus Microscopic Transsphenoidal Surgery for Patients with Growth Hormone Secreting Pituitary Adenoma: an Emulated Trial

Pseudocapsule-Based Resection for Pituitary Adenomas via the Endoscopic Endonasal Approach

The Diagnosis and Treatment of Growth Hormone Secreting Pituitary Adenomas: Analysis of 95 Cases

Surgical Results and Predictors of Initial and Delayed Remission for Growth Hormone-Secreting Pituitary Adenomas Using the 2010 Consensus Criteria in 162 Patients from a Single Center

Surgical Outcome and Evaluation of Strategies in the Management of Growth Hormone-Secreting Pituitary Adenomas After Initial Transsphenoidal Pituitary Adenectomy Failure

Endoscopic Extrapseudocapsular Resection of Pituitary Adenoma Using Bilateral Endonasal Approach

A single-center experience of transsphenoidal endoscopic surgery for acromegaly in 73 patients: results and predictive factors for remission

Transnasal Endoscopic Surgery for Pituitary Adenomas

Expanded endoscopic endonasal approach for resection of residual parasellar growth hormone-secreting pituitary adenoma in a patient with kissing internal carotid arteries: Technical nuances

Endoscopic-assisted Transsphenoidal Approach for the Resection of Pituitary Adenoma

Neuroendoscopic microsurgical treatment of pituitary adenomas using bilateral endonasal approach with fixed arm

Presurgical Treatment with Somatostatin Analogues in Growth Hormone-Secreting Pituitary Adenomas: A Long-Term Single-Center Experience

Efficacy of transsphenoidal surgery in achieving biochemical cure of growth hormone-secreting pituitary adenomas among patients with cavernous sinus invasion: a systematic review and meta-analysis

Effects of transsphenoidal surgery on anterior pituitary function in growth hormone-secreting pituitary adenomas and analysis of related factors

Surgical treatment of giant pituitary adenomas via transsphenoidal approach